7 Most Concerning Stocks To Watch in August

[ad_1]

  • Stock price as of Aug. 4, 2022: $37.46

Teladoc Health has taken an absolute beating in 2022, down about 58% year-to-date as of Aug. 4. At recent prices, the former darling of the pandemic has plummeted a whopping 87% from its 2021 all-time high of $294.54.

At these levels, the stock has perhaps unsurprisingly generated some interest among bargain hunters, who feel that any stock down that much is a “value.” While that may indeed be the case over the long run, the short-term outlook for the stock is decidedly negative.

In April, the stock reported a huge loss and cut its full-year outlook, and shares tanked nearly 50% in response. Things weren’t much better in July, when the company reported yet another outsized loss, slashed forward estimates and endured a 20% stock drop.

On Aug. 2, two Wall Street analysts cut their ratings on the stock, voicing concerns about the company’s near-term performance. Although the stock may still have long-term legs, shares should likely be avoided in August.

Take Our Poll: Do You Tip for Service?

[ad_2]

Source link

  • Stock price as of Aug. 4, 2022: $37.46

Teladoc Health has taken an absolute beating in 2022, down about 58% year-to-date as of Aug. 4. At recent prices, the former darling of the pandemic has plummeted a whopping 87% from its 2021 all-time high of $294.54.

At these levels, the stock has perhaps unsurprisingly generated some interest among bargain hunters, who feel that any stock down that much is a “value.” While that may indeed be the case over the long run, the short-term outlook for the stock is decidedly negative.

In April, the stock reported a huge loss and cut its full-year outlook, and shares tanked nearly 50% in response. Things weren’t much better in July, when the company reported yet another outsized loss, slashed forward estimates and endured a 20% stock drop.

On Aug. 2, two Wall Street analysts cut their ratings on the stock, voicing concerns about the company’s near-term performance. Although the stock may still have long-term legs, shares should likely be avoided in August.

Take Our Poll: Do You Tip for Service?

Add a Comment

Your email address will not be published. Required fields are marked *